201-300

201. Carabello BA, Usher BW, Hendrix GH, et al. Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular
dysfunction: a change in the measuring stick. J Am Coll Cardiol 1987; 10: 991-997.
202. Daniel WG, Hood WP, Jr., Siart A, et al. Chronic aortic regurgitation: reassessment of the prognostic value of preoperative left ventricular end-systolic
dimension and fractional shortening. Circulation 1985; 71: 669-680.
203. Fioretti P, Roelandt J, Bos RJ, et al. Echocardiography in chronic aortic insufficiency. Is valve replacement too late when left ventricular end-systolic
dimension reaches 55 mm? Circulation 1983; 67: 216-221.
204. Dujardin KS, Enriquez-Sarano M, Schaff HV, et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study.
Circulation 1999; 99:1851-1857.
205. Tornos P, Sambola A, Permanyer-Miralda G, et al. Longterm outcome of surgically treated aortic regurgitation: influence of guideline adherence toward
early surgery. J Am Coll Cardiol 2006; 47: 1012-1017.
206. Taniguchi K, Kawamaoto T, Kuki S, et al. Left ventricular myocardial remodeling and contractile state in chronic aortic regurgitation. Clin Cardiol 2000;
23: 608-614.
207. Henry WL, Bonow RO, Rosing DR, et al. Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial
echocardiographic evaluation of asymptomatic patients. Circulation 1980; 61: 484-492.
208. Daimon M, Watanabe H, Abe Y, et al. Normal values of echocardiographic parameters in relation to age in a healthy Japanese population: the JAMP
study. Circ J 2008; 72: 1859-1866.
209. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s
Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of
Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
210. Burwash IG, Thomas DD, Sadahiro M, et al. Dependence of Gorlin formula and continuity equation valve areas on transvalvular volume flow rate in
valvular aortic stenosis. Circulation 1994; 89: 827-835.
211. Kadem L, Rieu R, Dumesnil JG, et al. Flow-dependent changes in Doppler-derived aortic valve effective orifice area are real and not due to artifact.
J Am Coll Cardiol 2006; 47: 131-137.
212. Basso C, Boschello M, Perrone C, et al . An echocardiographic survey of primary school children for bicuspid aortic valve. Am J Cardiol 2004; 93: 661
-663.
213. Ward C. Clinical significance of the bicuspid aortic valve. Heart 2000; 83: 81-85.
214. Osler W. Trans Assoc Am Physicians, 2. 1886: 185-192.
215. Bonderman D, Gharehbaghi-Schnell E, Wollenek G, et al. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation
1999; 99: 2138-2143.
216. Hahn RT, Roman MJ, Mogtader AH, et al. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am
Coll Cardiol 1992; 19: 283-288.
217. Niwa K, Perloff JK, Bhuta SM, et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic
analyses. Circulation 2001; 103: 393-400.
218. Pachulski RT, Weinberg AL, Chan KL. Aortic aneurysm in patients with functionally normal or minimally stenotic bicuspid aortic valve. Am J Cardiol
1991; 67: 781-782.
219. Campbell M. The natural history of congenital aortic stenosis. Br Heart J 1968; 30: 514-526.
220. Campbell M. Calcific aortic stenosis and congenital bicuspid aortic valves. Br Heart J 1968; 30: 606-616.
221. Michelena HI, Desjardins VA, Avierinos JF, et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional
bicuspid aortic valve in the community. Circulation 2008; 117: 2776-2784.
222. Tzemos N, Therrien J, Yip J, et al. Outcomes in adults with bicuspid aortic valves. JAMA 2008; 300: 1317-1325.
223. Nkomo VT, Enriquez-Sarano M, Ammash NM, et al. Bicuspid aortic valve associated with aortic dilatation: a community-based study. Arterioscler
Thromb Vasc Biol 2003; 23: 351-356.
224. Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis:
a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of
Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;
52: 676-685.
225. Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N
Engl J Med 1994; 330: 1335-1341.
226. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the
American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the
Management of Adults With Congenital Heart Disease).Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm
Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic
Surgeons. J Am Coll Cardiol 2008; 52: e143-e263.
227. Nagashima H, Sakomura Y, Aoka Y, et al. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial
degeneration associated with Marfan’s syndrome. Circulation 2001; 104(12 Suppl 1): I282-I287.
228. Cribier A, Savin T, Saoudi N, et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve
replacement? Lancet 1986; 1: 63-67.
229. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients
with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing
Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular
Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523-e661.
230. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis.
Circulation 1994; 89:642-650.
231. O’Keefe JH, Jr., Vlietstra RE, Bailey KR, et al. Natural history of candidates for balloon aortic valvuloplasty. Mayo Clin Proc 1987; 62: 986-991.
232. Moreno PR, Jang IK, Newell JB, et al. The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic
stenosis. J Am Coll Cardiol 1994; 23: 1071-1075.
233. Rahimtoola SH. Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role. J Am Coll Cardiol 1994; 23: 1076-1078.
234. Hara H, Pedersen WR, Ladich E, et al. Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance? Circulation 2007; 115: e334-e338.
235. Bruschi G, de Marco F, Botta L, et al. Direct Aortic Access for Transcatheter Self-Expanding Aortic Bioprosthetic Valves Implantation. Ann Thorac
Surg 2012; 94: 497-503.
236. Leon MB, Smith CR, Mack M, et al. Transcatheter aorticvalve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med
2010; 363: 1597-1607.
237. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
238. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left
ventricular dysfunction. J Am Coll Cardiol 2002; 39: 1356-1363.
239. Ambler G, Omar RZ, Royston P, et al. Generic, simple risk stratification model for heart valve surgery. Circulation 2005; 112: 224-231.
240. Nashef SA, Roques F, Hammill BG, et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American
cardiac surgery. Eur J Cardiothorac Surg 2002; 22: 101-105.
241. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac
Surg 2003; 75: 1856-1864.
242. Byrne JG, Karavas AN, Mihaljevic T, et al. Role of the cryopreserved homograft in isolated elective aortic valve replacement. Am J Cardiol 2003;
91: 616-619.
243. Emery RW, Erickson CA, Arom KV, et al. Replacement of the aortic valve in patients under 50 years of age: long-term follow-up of the St. Jude
Medical prosthesis. Ann Thorac Surg 2003; 75: 1815-1819.
244. Murday AJ, Hochstitzky A, Mansfield J, et al. A prospective controlled trial of St. Jude versus Starr Edwards aortic and mitral valve prostheses. Ann
Thorac Surg 2003; 76: 66-73.
245. Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative
intervention. Circulation 1990; 82: 124-139.
246. Cohen G, Christakis GT, Joyner CD, et al. Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. Ann
Thorac Surg 2002; 73: 767-775.
247. Kouchoukos NT, Davila-Roman VG, Spray TL, et al. Replacement of the aortic root with a pulmonary autograft in children and young adults with
aortic-valve disease. N Engl J Med 1994; 330: 1-6.
248. Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967; 2: 956-958.
249. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.
Circulation 2004; 109: 2302-2308.
250. Borger MA, Preston M, Ivanov J, et al. Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac
Cardiovasc Surg 2004; 128: 677-683.
251. Filsoufi F, Aklog L, Adams DH, et al. Management of mild to moderate aortic stenosis at the time of coronary artery bypass grafting. J Heart Valve Dis
2002; 11, Suppl 1: S45-S49.
252. Gillinov AM, Garcia MJ. When is concomitant aortic valve replacement indicated in patients with mild to moderate stenosis undergoing coronary
revascularization? Curr Cardiol Rep 2005; 7: 101-104.
253. Pereira JJ, Balaban K, Lauer MS, et al. Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery.
Am J Med 2005; 118: 735-742.
254. Smith WT, Ferguson TB, Jr., Ryan T, et al. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo
concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol 2004; 44: 1241-1247.
255. Karagounis A, Valencia O, Chandrasekaran V, et al. Management of patients undergoing coronary artery bypass graft surgery with mild to moderate
aortic stenosis. J Heart Valve Dis 2004; 13: 369-373.
256. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll
Cardiol 2000; 36: 1131-1141.
257. Jamieson WR, Ye J, Higgins J, et al. Effect of prosthesispatient mismatch on long-term survival with aortic valve replacement: assessment to 15
years. Ann Thorac Surg 2010; 89: 51-58.
258. Koch CG, Khandwala F, Estafanous FG, et al. Impact of prosthesis-patient size on functional recovery after aortic valve replacement. Circulation 2005;
111: 3221-3229.
259. Moon MR, Pasque MK, Munfakh NA, et al. Prosthesispatient mismatch after aortic valve replacement: impact of age and body size on late survival.
Ann Thorac Surg 2006;81: 481-488.
260. Moon MR, Lawton JS, Moazami N, et al. POINT: Prosthesis-patient mismatch does not affect survival for patients greater than 70 years of age
undergoing bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg 2009; 137: 278-283.
261. Penta de PA, Zeitani J, Nardi P, et al. Small "functional" size after mechanical aortic valve replacement: no risk in young to middle-age patients. Ann
Thorac Surg 2005; 79: 1915-1920.
262. Head SJ, Mokhles MM, Osnabrugge RL, et al. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a
systematic review and metaanalysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J 2012; 33: 1518-1529.
263. Filsoufi F, Rahmanian PB, Castillo JG, et al. Excellent early and late outcomes of aortic valve replacement in people aged 80 and older. J Am Geriatr
Soc 2008; 56: 255-261.
264. Leontyev S, Walther T, Borger MA, et al. Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg
2009; 87: 1440-1445.
265. Saxena A, Poh CL, Dinh DT, et al. Early and late outcomes after isolated aortic valve replacement in octogenarians: an Australasian Society of
Cardiac and Thoracic Surgeons Cardiac Surgery Database Study. Eur J Cardiothorac Surg 2012; 41: 63-68.
266. Bonow RO, Picone AL, McIntosh CL, et al. Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of
preoperative left ventricular function. Circulation 1985; 72: 1244-1256.
267. Klodas E, Enriquez-Sarano M, Tajik AJ, et al. Aortic regurgitation complicated by extreme left ventricular dilation: long-term outcome after surgical
correction. J Am Coll Cardiol 1996; 27: 670-677.
268. Tornos MP, Olona M, Permanyer-Miralda G, et al. Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow
-up study. Am Heart J 1995; 130: 333-339.
269. Detaint D, Messika-Zeitoun D, Maalouf J, et al. Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic
regurgitation: a prospective study. JACC Cardiovasc Imaging 2008; 1: 1-11.
270. Detaint D, Maalouf J, Tribouilloy C, et al. Congestive heart failure complicating aortic regurgitation with medical and surgical management: a
prospective study of traditional and quantitative echocardiographic markers. J Thorac Cardiovasc Surg 2008; 136: 1549-1557.
271. 吉川純一，他．大動脈弁逆流，弁膜疾患の手術適応と至適時期．今日の心臓手術の適応と至適時期．伊藤浩，他編．文光堂，東京 2011: 108-112.
272. Klodas E, Enriquez-Sarano M, Tajik AJ, et al. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms.
J Am Coll Cardiol 1997; 30: 746-752.
273. Bonow RO, Rosing DR, McIntosh CL, et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function.
Circulation 1983; 68: 509-517.
274. Fukuda J, Hayashi J, Yoshimura T, et al. Myocardial structure in volume-overloaded hearts before and after valve replacement. Jpn Circ J 1986; 50:
1033-1039.
275. Taniguchi K, Nakano S, Hirose H, et al. Preoperative left ventricular function: minimal requirement for successful late results of valve replacement for
aortic regurgitation. J Am Coll Cardiol 1987; 10: 510-518.
276. Carabello BA, Crawford FA, Jr. Valvular heart disease. N Engl J Med 1997; 337: 32-41.
277. Taniguchi K, Nakano S, Matsuda H, et al. Depressed myocardial contractility and normal ejection performance after aortic valve replacement in
patients with aortic regurgitation. J Thorac Cardiovasc Surg 1989; 98: 258-265.
278. Taniguchi K, Nakano S, Kawashima Y, et al. Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and
after aortic valve replacement. Circulation 1990; 82: 798-807.
279. Bonow RO, Borer JS, Rosing DR, et al. Preoperative exercise capacity in symptomatic patients with aortic regurgitation as a predictor of postoperative
left ventricular function and long-term prognosis. Circulation 1980; 62: 1280-1290.
280. Casselman FP, Gillinov AM, Akhrass R, et al. Intermediateterm durability of bicuspid aortic valve repair for prolapsing leaflet. Eur J Cardiothorac Surg
1999; 15: 302-308.
281. Langer F, Aicher D, Kissinger A, et al. Aortic valve repair using a differentiated surgical strategy. Circulation 2004; 110(11 Suppl 1): II67-II73.
282. Minakata K, Schaff HV, Zehr KJ, et al. Is repair of aortic valve regurgitation a safe alternative to valve replacement? J Thorac Cardiovasc Surg 2004;
127: 645-653.
283. David TE, Feindel CM, Webb GD, et al. Long-term results of aortic valve-sparing operations for aortic root aneurysm. J Thorac Cardiovasc Surg 2006;
132: 347-354.
284. Yacoub M. Valve-conserving operation for aortic root aneurysm or dissection. Operative Techniques in Cardio and Thoracic Surgery 1996; 1: 57-67.
285. Boodhwani M, de KL, Glineur D, et al. Repair-oriented classification of aortic insufficiency: impact on surgical techniques and clinical outcomes. J
Thorac Cardiovasc Surg 2009; 137: 286-294.
286. Schafers HJ, Aicher D, Langer F, et al. Preservation of the bicuspid aortic valve. Ann Thorac Surg 2007; 83: S740-S745.
287. Bach DS, Kon ND, Dumesnil JG, et al. Ten-year outcome after aortic valve replacement with the freestyle stentless bioprosthesis. Ann Thorac Surg
2005; 80: 480-486.
288. Oury JH, Hiro SP, Maxwell JM, et al. The Ross Procedure: current registry results. Ann Thorac Surg 1998; 66(6 Suppl): S162-S165.
289. O’Brien MF, Stafford EG, Gardner MA, et al. Allograft aortic valve replacement: long-term follow-up. Ann Thorac Surg 1995; 60(2 Suppl): S65-S70.
290. Aoyagi S, Oryoji A, Nishi Y, et al. Long-term results of valve replacement with the St. Jude Medical valve. J Thorac Cardiovasc Surg 1994; 108:
1021-1029.
291. Nakano K, Koyanagi H, Hashimoto A, et al. Twelve years’experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg 1994; 57: 697-702.
292. Assey ME, Spann JF, Jr. Indications for heart valve replacement. Clin Cardiol 1990; 13: 81-88.
293. de KL, Glineur D, Poncelet A, et al. Repair of aortic leaflet prolapse: a ten-year experience. Eur J Cardiothorac Surg 2008; 34: 785-791.
294. Klodas E, Enriquez-Sarano M, Tajik AJ, et al. Surgery for aortic regurgitation in women. Contrasting indications and outcomes compared with men.
Circulation 1996; 94: 2472-2478.
295. De PR, Bobbio M, Ottino G, et al. The De Vega tricuspid annuloplasty. Perioperative mortality and long term followup. J Cardiovasc Surg (Torino)
1990; 31: 512-517.
296. Fukuda S, Saracino G, Matsumura Y, et al. Threedimensional geometry of the tricuspid annulus in healthy subjects and in patients with functional
tricuspid regurgitation: a real-time, 3-dimensional echocardiographic study. Circulation 2006; 114(1 Suppl): I492-I498.
297. Colombo T, Russo C, Ciliberto GR, et al. Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid
valve repair. Cardiovasc Surg 2001; 9: 369-377.
298. Kay JH, Maselli-Campagna G, Tsuji HK. Surgical treatment of tricuspid insufficiency. Ann Surg 1965; 162: 53-58.
299. De Vega NG. Selective, adjustable and permanent annuloplasty. An original technic for the treatment of tricuspid insufficiency. Rev Esp Cardiol
1972; 25: 555-556.
300. Carpentier A. Cardiac valve surgery-the "French correction". J Thorac Cardiovasc Surg 1983; 86: 323-337.

文献